Obstetrix Medical Group

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Obstetrix Medical Group sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials none currently recruiting 7 completed top decile by trial count

Obstetrix Medical Group: 9 sponsored US clinical trials, none currently recruiting.

Obstetrix Medical Group sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 2 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Preterm Delivery, with 1 trials.

Top-decile sponsor footprint

Obstetrix Medical Group ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

9 total, page 1 of 1

COMPLETED

Optimal Management of Vasa Previa Study - A Retrospective Study

NCT01977040
COMPLETED

National Prevalence and Impact of Noninvasive Prenatal Testing

NCT02284399
COMPLETED

Neonatal Outcome by Reason for Delivery

NCT01818518
COMPLETED

Maternal Uterine Artery Doppler Study

NCT01698957
COMPLETED Phase 2

Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM)

NCT01119963
TERMINATED

Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

NCT00143039
COMPLETED Phase 2

17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies

NCT00163020
TERMINATED Phase 4

Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)

NCT00201656
COMPLETED Phase 4

A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome

NCT00201643

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 4 2

Therapeutic Areas

Preterm Delivery 1

How the Obstetrix Medical Group archive is shaped

9 indexed studies, none listed as recruiting (0% open); 7 completed (78%).

Phase mix: 2 late (III/IV) vs 2 early (I/II) (balanced across stages).

Top condition: Preterm Delivery (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Obstetrix Medical Group: archived-pipeline peers nationwide

Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Obstetrix Medical Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40%50% Total trials Recruiting share Obstetrix Medical Group4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi company10xBio22nd Century Group23andMe3-C Institute for Social Development
Obstetrix Medical Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Obstetrix Medical Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Obstetrix Medical Group page

9 registered trials is a research-attention snapshot, not an endorsement of Obstetrix Medical Group or any single study.

  • None of Obstetrix Medical Group's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Preterm Delivery is the condition Obstetrix Medical Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Preterm Delivery trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Obstetrix Medical Group pipeline card: 9 registered trials from official public datasets.Report a data error.